Page last updated: 2024-09-02

morpholinoanthracycline mx2 and Neoplasms

morpholinoanthracycline mx2 has been researched along with Neoplasms in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	4 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Clark, GM; Ebrahim el-Zayat, AA; Izquierdo, MA; Von Hoff, DD	1
Basser, RL; Cebon, J; Clarke, K; Geldard, H; Green, MD; Hill, JS; Kaye, AH; Maher, DW; Morgan, DJ; Park, SJ; Stylli, SS	2
Alt, C; Bartlett, J; Basser, RL; Cebon, J; Clarke, K; Fox, RM; Geldard, H; Green, MD; Hill, JS; Kaye, AH; Maher, D; Morgan, DJ	1

Trials

3 trial(s) available for morpholinoanthracycline mx2 and Neoplasms

Article	Year
Pharmacokinetics and pharmacodynamics of MX2 hydrochloride in patients with advanced malignant disease. Cancer chemotherapy and pharmacology, 1997, Volume: 40, Issue:3 Topics: Adult; Aged; Antibiotics, Antineoplastic; Area Under Curve; Carubicin; Doxorubicin; Female; Half-Life; Humans; Injections, Intravenous; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Neutropenia; Neutrophils; Safety	1997
Effect of filgrastim on the pharmacokinetics of MX2 hydrochloride in patients with advanced malignant disease. Cancer chemotherapy and pharmacology, 1998, Volume: 41, Issue:5 Topics: Antibiotics, Antineoplastic; Area Under Curve; Carubicin; Dose-Response Relationship, Drug; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Metabolic Clearance Rate; Neoplasms; Neutrophils; Recombinant Proteins	1998
Phase I and pharmacokinetic study of KRN8602 alone and with filgrastim in patients with advanced cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1998, Volume: 16, Issue:6 Topics: Adult; Aged; Antibiotics, Antineoplastic; Carubicin; Dose-Response Relationship, Drug; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Recombinant Proteins; Treatment Outcome	1998

Other Studies

1 other study(ies) available for morpholinoanthracycline mx2 and Neoplasms

Article	Year
Activity of the morpholino anthracycline 3'-deamino-3'-morpholino-13-deoxo-10-hydroxycarminomycin (MX2) against human tumor colony-forming units in vitro. Investigational new drugs, 1995, Volume: 13, Issue:2 Topics: Antibiotics, Antineoplastic; Carubicin; Cell Division; Cell Survival; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Drugs, Investigational; Humans; Neoplasms; Neoplastic Stem Cells; Tumor Cells, Cultured; Tumor Stem Cell Assay	1995

Article

Year

Activity of the morpholino anthracycline 3'-deamino-3'-morpholino-13-deoxo-10-hydroxycarminomycin (MX2) against human tumor colony-forming units in vitro.

Investigational new drugs, 1995, Volume: 13, Issue:2

Topics: Antibiotics, Antineoplastic; Carubicin; Cell Division; Cell Survival; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Drugs, Investigational; Humans; Neoplasms; Neoplastic Stem Cells; Tumor Cells, Cultured; Tumor Stem Cell Assay

1995